A Lucchini Selected Research

A Lucchini Research Topics

2	COVID-19 07/2022 - 05/2022
2	Tuberculosis (Tuberculoses) 02/2012 - 07/2008
2	Pulmonary Hypertension 08/2006 - 04/2005
1	Infections 05/2022
1	Lymphoma (Lymphomas) 06/2018
1	Acute Lung Injury 01/2014
1	Neoplasms (Cancer) 02/2012
1	Necrosis 06/2009
1	Reperfusion Injury 06/2009
1	Disease Progression 07/2008
1	Opioid-Related Disorders (Opiate Addiction) 09/2007
1	Substance-Related Disorders (Drug Abuse) 09/2007
1	Heroin Dependence (Heroin Abuse) 09/2006
1	Ventilator-Associated Pneumonia 04/2003
1	Respiratory Tract Infections (Respiratory Tract Infection) 04/2003
1	Critical Illness (Critically Ill) 04/2003

1	Biomarkers (Surrogate Marker)IBA 05/2022
1	Lopinavir FDA Link 02/2012
1	Enfuvirtide (Fuzeon)FDA Link 02/2012
1	NucleosidesIBA 02/2012
1	Reverse Transcriptase InhibitorsIBA 02/2012
1	Ritonavir (Norvir)FDA Link 02/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2009
1	CaspasesIBA 06/2009
1	salicylhydroxamic acid (SHAM)IBA 06/2009
1	CytokinesIBA 06/2009
1	Rifampin (Rifampicin)FDA LinkGeneric 07/2008
1	RifamycinsIBA 07/2008
1	Moxifloxacin (Avelox)FDA Link 07/2008
1	Rifabutin (Ansamycin)FDA Link 07/2008
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 09/2007
1	Heroin (Diamorphine)IBA 09/2007
1	Messenger RNA (mRNA)IBA 09/2007
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 09/2006
1	BenzodiazepinesIBA 09/2006
1	Opioid Analgesics (Opioids)IBA 09/2006
1	Olanzapine (Zyprexa)FDA Link 09/2006
1	Bosentan (Tracleer)FDA Link 08/2006

2	Highly Active Antiretroviral Therapy (HAART) 08/2006 - 04/2005
1	Continuous Positive Airway Pressure 07/2022
1	Drug Therapy (Chemotherapy) 06/2018
1	Transportation of Patients 01/2014
1	Transplantation 06/2009
1	Contraindications 07/2008
1	Artificial Respiration (Mechanical Ventilation) 04/2003